Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

Beyond cancer vaccine, how did Merck’s oncology pipeline do at #ESMO26?

MADRID — Much of the coverage on Merck at the European Society for Medical Oncology congress centered on its Moderna-partnered cancer vaccine trial. But the company is actually at the meeting with more than two ...

We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.

Read the original at endpoints.news →

More in Health & Medicine

More from Monday 26 October →